We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
Cap. Flow
-$2.43B
Cap. Flow %
-3.41%
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$353M
2
MRVL icon
Marvell Technology
MRVL
+$150M
3
SYRE icon
Spyre Therapeutics
SYRE
+$126M
4
BBIO icon
BridgeBio Pharma
BBIO
+$116M
5
DOV icon
Dover
DOV
+$110M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$713M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$355M
3
CTRA
Coterra Energy
CTRA
+$289M
4
RPRX icon
Royalty Pharma
RPRX
+$259M
5
LLY icon
Eli Lilly
LLY
+$236M

Sector Composition

Rank Sector Weight
1 Technology 32.29%
2 Healthcare 14.03%
3 Financials 12.39%
4 Industrials 8.94%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIDZW
1001
KIDZ AI Inc Warrants
KIDZW
$173K
$2.22K ﹤0.01%
176,533
– –
ABUS icon
1002
Arbutus Biopharma
ABUS
$1.02B
– –
-2,664,941
Closed -$12M
AFG icon
1003
American Financial Group
AFG
$11.6B
– –
-15,000
Closed -$1.92M
ALGN icon
1004
Align Technology
ALGN
$10.9B
– –
-130,314
Closed -$22.3M
ALHC icon
1005
Alignment Healthcare
ALHC
$2.7B
– –
-1,050,174
Closed -$18.5M
ALXO icon
1006
ALX Oncology
ALXO
$254M
– –
-2,000,000
Closed -$4.01M
ASMB icon
1007
Assembly Biosciences
ASMB
$669M
– –
-161,000
Closed -$4.47M
ATI icon
1008
ATI
ATI
$28.1B
– –
-10,468
Closed -$1.52M
BANC icon
1009
Banc of California
BANC
$2.92B
– –
-32,907
Closed -$579K
BSX icon
1010
PUT
Boston Scientific
BSX
$65.2B
– –
-250,000
Closed -$15.7M
CAG icon
1011
Conagra Brands
CAG
$7.25B
– –
-426,845
Closed -$6.71M
CDE icon
1012
Coeur Mining
CDE
$21.6B
– –
-275,000
Closed -$5.16M
CINF icon
1013
Cincinnati Financial
CINF
$26B
– –
-10,469
Closed -$1.65M
CNTA
1014
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-8,925,010
Closed -$355M
CNTX icon
1015
Context Therapeutics
CNTX
$34M
– –
-1,000,000
Closed -$2.62M
CPT icon
1016
Camden Property Trust
CPT
$12B
– –
-67,300
Closed -$6.57M
CTLP
1017
DELISTED
Cantaloupe
CTLP
– –
-625,661
Closed -$6.76M
CTRA
1018
DELISTED
Coterra Energy
CTRA
– –
-8,219,512
Closed -$289M
CWAN
1019
DELISTED
Clearwater Analytics
CWAN
– –
-935,000
Closed -$22.1M
DAL icon
1020
Delta Air Lines
DAL
$51.8B
– –
-781,911
Closed -$52M
DG icon
1021
Dollar General
DG
$27.5B
– –
-132,200
Closed -$15.7M
DUK icon
1022
Duke Energy
DUK
$93.9B
– –
-230,113
Closed -$30.1M
ED icon
1023
Consolidated Edison
ED
$39.8B
– –
-278,344
Closed -$31.5M
EPAM icon
1024
EPAM Systems
EPAM
$5.92B
– –
-29,300
Closed -$3.97M
EPRT icon
1025
Essential Properties Realty Trust
EPRT
$6.4B
– –
-400,000
Closed -$12.1M
39 40
41
42 43

Similar funds

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Adage Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.

  • Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
  • Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
  • Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
  • Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
  • Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
  • Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.